145 related articles for article (PubMed ID: 21050999)
1. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care.
Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
Womens Health Issues; 2010; 20(6):400-5. PubMed ID: 21050999
[TBL] [Abstract][Full Text] [Related]
2. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women.
Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
Med Care; 2011 Jan; 49(1):89-95. PubMed ID: 21079524
[TBL] [Abstract][Full Text] [Related]
3. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of a Medicaid expansion for cancer care: The Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Lantz PM; Soliman S
Womens Health Issues; 2009; 19(4):221-31. PubMed ID: 19589471
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Population Screening Program Results in Early Detection and Reduced Treatment and Health Care Costs for Medicaid.
Homan SG; Yun S; Bouras A; Schmaltz C; Gwanfogbe P; Lucht J
J Public Health Manag Pract; 2021; 27(1):70-79. PubMed ID: 31592983
[TBL] [Abstract][Full Text] [Related]
6. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
Ku L; Bysshe T; Steinmetz E; Bruen BK
Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
[TBL] [Abstract][Full Text] [Related]
7. The effect of the Breast and Cervical Cancer Prevention and Treatment Act on Medicaid disenrollment.
Chien LN; Adams EK
Womens Health Issues; 2010; 20(4):266-71. PubMed ID: 20627776
[TBL] [Abstract][Full Text] [Related]
8. State Medicaid expansion decisions and disparities in women's cancer screening.
Sabik LM; Tarazi WW; Bradley CJ
Am J Prev Med; 2015 Jan; 48(1):98-103. PubMed ID: 25441234
[TBL] [Abstract][Full Text] [Related]
9. Impact of chronic conditions on the cost of cancer care for Medicaid beneficiaries.
Subramanian S; Tangka FK; Sabatino SA; Howard D; Richardson LC; Haber S; Halpern MT; Hoover S
Medicare Medicaid Res Rev; 2012; 2(4):. PubMed ID: 24800160
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
11. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific treatment costs for cervical cancer in the United Kingdom.
Wolstenholme JL; Whynes DK
Eur J Cancer; 1998 Nov; 34(12):1889-93. PubMed ID: 10023311
[TBL] [Abstract][Full Text] [Related]
13. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
14. The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada.
Righolt CH; Pabla G; Mahmud SM
Appl Health Econ Health Policy; 2018 Apr; 16(2):195-205. PubMed ID: 29299769
[TBL] [Abstract][Full Text] [Related]
15. Late stage cancers in a Medicaid-insured population.
Bradley CJ; Given CW; Roberts C
Med Care; 2003 Jun; 41(6):722-8. PubMed ID: 12773838
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
[TBL] [Abstract][Full Text] [Related]
17. Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system.
Tang CH; Pwu RF; Tsai IC; Wang HI; You SL; Chen CA; Scuffham PA; Hsieh CY; Chou CY; Lin SR; Chen YD; Chen CJ
Arch Gynecol Obstet; 2010 Apr; 281(4):683-95. PubMed ID: 19730873
[TBL] [Abstract][Full Text] [Related]
18. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas.
Fu S; Fokom Domgue J; Chan W; Zhao B; Ramondetta LM; Lairson DR
J Low Genit Tract Dis; 2019 Apr; 23(2):102-109. PubMed ID: 30907776
[TBL] [Abstract][Full Text] [Related]
19. The Breast and Cervical Cancer Prevention and Treatment Act in Georgia: effects on time to Medicaid enrollment.
Adams EK; Chien LN; Florence CS; Raskind-Hood C
Cancer; 2009 Mar; 115(6):1300-9. PubMed ID: 19189369
[TBL] [Abstract][Full Text] [Related]
20. Incidence and costs of cervical intraepithelial neoplasia in the Korean population.
Chang HK; Seo SS; Myong JP; Yu YL; Byun SW
J Gynecol Oncol; 2019 May; 30(3):e37. PubMed ID: 30887758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
